| 產品名稱 | PF 05081090 - PF 5081090 |
| 產品貨號 | Axon 2113 CAS [1312473-63-4] MF C18H21FN2O6SMW 412.43 Purity: 98% Optical purity: Optically pure Soluble in DMSO Description Very potent antibacterial LpxC inhibitor for the treatment of serious gram-negative infections (Pseudomonas aeruginosa (Pae) enzyme potency (Pae IC50) of 1.1 nM) References Certificates Categories Extra info JI Montgomery et al. Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections. J. Med. Chem. 2012, 55(4), 1662-1670.?? ? MF Brown et al. Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections. J. Med. Chem. 2012, 55(2), 914–923.?? Certificate of Analysis Material Safety Data Sheet Immunology LpxC EC 3.5.1.108 Pfizer Licensed Products Antibiotics LpxC inhibitor for treatment of gram-negative infections Chemical name (R)-4-(4-(2-fluoro-4-methoxyphenyl)-2-oxopyridin-1(2H)-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [1312473-63-4] Order Size Unit Price Stock 5 mg €95.00 In Stock |
| 產品價格 | 現貨詢價，電話：010-67529703 |
| 產品規格 | |
| 產品品牌 | axonmedchem |
| 產品概述 | |
| 產品詳情 |
PF 05081090 - PF 5081090Axon 2113 CAS [1312473-63-4] MF C18H21FN2O6S
Description
Very potent antibacterial LpxC inhibitor for the treatment of serious gram-negative infections (Pseudomonas aeruginosa (Pae) enzyme potency (Pae IC50) of 1.1 nM)
LpxC inhibitor for treatment of gram-negative infections
Chemical name(R)-4-(4-(2-fluoro-4-methoxyphenyl)-2-oxopyridin-1(2H)-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[1312473-63-4] |
| 產品資料 |
